Local anesthetics are used routinely and effectively. However,
many are also known to activate neurotoxic pathways. We tested the neuroprotective
efficacy of ginkgolide B (GB), an active component of Ginkgo biloba, against
ROS-mediated neurotoxicity caused by the local anesthetic bupivacaine.
SH-SY5Y cells were treated with different concentrations of bupivacaine
alone or following preincubation with GB. Pretreatment with GB increased
SH-SY5Y cell viability and attenuated intracellular ROS accumulation, apoptosis,
mitochondrial dysfunction, and ER stress. GB suppressed bupivacaine-induced
mitochondrial depolarization and mitochondria complex I and III inhibition and increased
cleaved caspase-3 and Htra2 expression, which was strongly indicative of activation of
mitochondria-dependent apoptosis with concomitantly enhanced expressions of Grp78,
caspase-12 mRNA, protein, and ER stress. GB also improved ultrastructural changes
indicative of mitochondrial and ER damage induced by bupivacaine. These results implicate
bupivacaine-induced ROS-dependent mitochondria, ER dysfunction, and apoptosis,
which can be attenuated by GB through its antioxidant property.